Uveitis and Ocular Inflammation

Managing intraocular inflammation requires precision and multidisciplinary coordination. Uveitis and ocular inflammation represent complex disorders that may arise from autoimmune diseases, infections, or systemic conditions. Accurate classification—whether anterior, intermediate, posterior, or pan-uveitis—guides the therapeutic pathway. The increasing use of imaging modalities like fluorescein angiography and OCT has significantly improved diagnostic precision, especially in detecting subclinical inflammation. Biologic agents and steroid-sparing immunomodulatory therapies now offer targeted relief while minimizing systemic side effects. Collaboration with rheumatologists and infectious disease specialists ensures underlying causes are addressed effectively. Advances in sustained-release drug delivery systems, including injectable implants, are extending control over chronic inflammation. Early intervention remains key to preserving vision, as chronic uveitis can lead to complications like glaucoma or macular edema if left untreated.